Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Your healthcare provider can ensure that the therapy aligns with your goals
If you are located in
Safety Profile: What Clinical Trials Actually Documented Across six clinical trials involving approximately 900 participants, AOD-9604 produced no treatment-related serious adverse events, no immunogenic response, no IGF-1 elevation, and no adverse cardiovascular or metabolic signals
Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase
Key scientific figures and citations AOD9604 is a synthetic peptide analogue of the lipolytic domain of human growth hormone that has been shown to reduce body weight in obese rodents without the diabetogenic effects of intact hGH. Ng FM
US$ 26.60
US$ 22.78
US$ 23.35
US$ 25.59
